Plasma-only multiomic minimal residual disease (MRD) testing in 2,000 consecutive patients with colorectal cancer (CRC).

Autor: Pedersen, Katrina Sophia, Tan, Benjamin R., Zuo, Xiaotong, Kiedrowski, Lesli A., Bucheit, Leslie
Zdroj: Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p28-28, 1p
Databáze: Supplemental Index